• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.

作者信息

Boietti B, Fili S, Peuchot V, Tabares A, Vázquez F, Gándara E

机构信息

Division of Internal Medicine, Hospital Italiano de Buenos Aires, Argentina.

Division of Internal Medicine, Hospital Privado de Comunidad, Mar del Plata, Argentina.

出版信息

Thromb Res. 2021 Aug;204:143-145. doi: 10.1016/j.thromres.2021.01.011. Epub 2021 Jan 26.

DOI:10.1016/j.thromres.2021.01.011
PMID:33593595
Abstract
摘要

相似文献

1
Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.在一个发展中国家，利伐沙班的使用对接受急性静脉血栓栓塞治疗患者住院时间的影响。
Thromb Res. 2021 Aug;204:143-145. doi: 10.1016/j.thromres.2021.01.011. Epub 2021 Jan 26.
2
Practical management of rivaroxaban for the treatment of venous thromboembolism.利伐沙班治疗静脉血栓栓塞症的实际管理
Clin Appl Thromb Hemost. 2015 May;21(4):309-18. doi: 10.1177/1076029613503397. Epub 2013 Sep 19.
3
Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program.日本利伐沙班治疗有症状静脉血栓栓塞症患者可缩短住院时间：J-EINSTEIN肺栓塞和深静脉血栓形成研究项目
Curr Med Res Opin. 2015 Jun;31(6):1057-61. doi: 10.1185/03007995.2015.1037728. Epub 2015 May 11.
4
Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.比较利伐沙班与传统抗凝剂治疗静脉血栓栓塞症患者的住院时间。
Lung. 2016 Aug;194(4):605-11. doi: 10.1007/s00408-016-9898-8. Epub 2016 May 18.
5
Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.利伐沙班与华法林治疗与预防静脉血栓栓塞复发的有效性和安全性。
Thromb Haemost. 2017 Oct 5;117(10):1841-1847. doi: 10.1160/TH17-03-0210. Epub 2017 Jun 22.
6
A treatment strategy using subcutaneous fondaparinux followed by oral rivaroxaban is effective for treating acute venous thromboembolism.采用皮下注射磺达肝癸钠后口服利伐沙班的治疗策略对治疗急性静脉血栓栓塞有效。
J Cardiol. 2017 Aug;70(2):163-168. doi: 10.1016/j.jjcc.2016.10.013. Epub 2016 Dec 12.
7
Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.直接Xa因子抑制剂（利伐沙班和阿哌沙班）与依诺肝素用于全膝关节置换术后预防静脉血栓栓塞：6项随机临床试验的荟萃分析
Thromb Res. 2015 May;135(5):816-22. doi: 10.1016/j.thromres.2015.02.008. Epub 2015 Feb 12.
8
Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.利伐沙班用于治疗静脉血栓栓塞症。103例患者的“真实生活”视角。
Thromb Res. 2014 Sep;134(3):617-21. doi: 10.1016/j.thromres.2014.06.032. Epub 2014 Jul 5.
9
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.口服利伐沙班对比标准抗凝治疗有症状的深静脉血栓形成的安全性和有效性（XALIA）：一项国际前瞻性非干预性研究。
Lancet Haematol. 2016 Jan;3(1):e12-21. doi: 10.1016/S2352-3026(15)00257-4. Epub 2015 Dec 8.
10
Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study.直接口服抗凝剂与华法林治疗静脉血栓栓塞症患者的住院时间：一项真实世界的单中心研究。
J Thromb Thrombolysis. 2018 Jul;46(1):16-21. doi: 10.1007/s11239-018-1661-y.